Schedule 13D ownership disclosure

Flex Pharma, Inc.

Security class unavailable · CUSIP: 33938A105

Event date: 2018-12-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,200,000
Percent of class
12.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001762003-18-000003
Form type
SC 13D
Filer
Boston Foundation, Inc.
CIK
CIK 1762003
Filed
Dec 28, 2018
Reporting period
Dec 20, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub